Chiesi Group and Oak Hill Bio Collaborate on OHB-607
-
Drug News
Chiesi Group and Oak Hill Bio Collaborate on OHB-607, a Neonatal Therapy
Chiesi Group, an international biopharmaceutical and healthcare group, and Oak Hill Bio, a neonatology and rare disease therapeutics company, have…
Read More »
